Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

Clinical trial NCT00973076 · COMPLETED

Trial details

NCT number: NCT00973076
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumors Advanced Solid Malignancies

Start date: 2009-08-01
Primary completion: 2010-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.